Oridion Announces Major Medical Research and Congress Presentations

    JERUSALEM and NEEDHAM, MA, Nov. 27 /CNW/ - Oridion Systems Ltd. (SWX:
ORIDN) Investigators have published sixteen major medical research project
findings that confirm the clinical benefit of end-tidal CO2 monitoring using
Microstream(R) capnography technology.
    These sixteen medical publications and presentations focus on Oridion
Microstream technology used across a full spectrum of patient populations
including Pain Management, Procedural Sedation, Emergency Medicine and
Critical Care - newborns through adults. These publications have been released
throughout the year 2007 at major international healthcare congresses.
    Significant findings from the medical research projects showed that
end-tidal CO2 is the best early indicator of breathing problems. Studies
conducted at leading universities and medical centers point out that the
Microstream response to breathing changes improves patient safety and reduces
risk during procedural sedation and patient controlled analgesia. A Duke
University study presented at the 2007 meeting of the American Society of
Anesthesiologists ("ASA") concluded that a successful post-operative
respiratory monitoring strategy designed to detect abnormal breathing would
require more than respiratory rate measurement. Microstream capnography will
immediately recognize changes in exhaled carbon dioxide and is more sensitive
to breathing alterations than respiratory rate or pulse oximetry as pointed
out in another US multi-center trial. Medical University of South Carolina
physician/scientists presented at the ASA research validating the importance
of capnography monitoring for early identification of airway problems during
procedural sedation.
    An early warning system, using Microstream capnography, is critical for
recognizing breathing problems during procedural sedation, as documented in
research by a French physician in his paper to the American Association for
Respiratory Care's annual congress ("AARC") and published in November's
Respiratory Care. The French study examines the limitation of pulse oximetry
as a respiratory monitoring technique. This report is one of six research
papers being presented at this year's AARC that demonstrates the clinical
value of Microstream technology.
    These sixteen international studies clearly demonstrate that capnography
needs to be included in a hospital's respiratory monitoring strategy.
    A full list of the 16 medical publications can be found on the Oridion
website: http://www.oridion.com/global/english/clinical_solutions/overview/
research.html. (Due to the length of this URL, it may be necessary to copy and
paste this hyperlink into your Internet browser's URL address field. Remove
the space if one exists.)

    Oridion is the global leader of innovative capnography monitoring
solutions helping to improve patient safety, and its Microstream(r)
capnography technology has become the standard of care in ventilation

    Certain statements made herein that are not historical are
forward-looking. The words "estimate" "project" "intend" "expect" "believe"
and similar expressions are intended to identify forward-looking statements.
These forward-looking statements involve known and unknown risks and
uncertainties. Many factors could cause the actual results, performance or
achievements of the Company to be materially different from any future
results, performance or achievements that may be expressed or implied by such
forward-looking statements, including, among others, our ability to maintain
profits, the market demands for our Capnography products, our ability to focus
our team on the Capnography business, changes in general economic and business
conditions, inability to maintain market acceptance to the Company's products,
inability to timely develop and introduce new technologies, products and
applications, rapid changes in the market for the Company's products, loss of
market share and pressure on prices resulting from competition, introduction
of competing products by other companies, inability to manage growth and
expansion, loss of key OEM partners, factors effecting OEM partners' position
in the market, inability to attract and retain qualified personnel, inability
to protect the Company's proprietary technology.

    website: http://oridion.com

For further information:

For further information: Alan Adler, Chairman and Chief Executive
Officer, Walter Tabachnik, Chief Financial Officer, Elena Gerberg, Investor
Relations, e-mail: investor@oridion.com, phone: +972-2-589-9159, address:
Oridion Systems Ltd., P.O. Box 45025, 91450 Jerusalem, Israel

Organization Profile


More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890